Analyze Diet
Journal of veterinary pharmacology and therapeutics1992; 15(2); 160-173; doi: 10.1111/j.1365-2885.1992.tb01003.x

Bioavailability and bioequivalence of veterinary drug dosage forms, with particular reference to horses: an overview.

Abstract: The route of administration and formulation of the dosage form affect the bioavailability (rate and extent of absorption) of a drug and may thereby influence the intensity and duration of the pharmacological effect. Location of injection site may affect the plasma concentration profile of drugs administered as aqueous suspensions or sustained release parenteral preparations (procaine penicillin G). When absorption influences the rate of elimination ('flip-flop' phenomenon), the apparent half-life of the drug will be increased (cefazolin sodium, i.m.; meclofenamic acid, p.o.). Absorption generally approximates a first-order process and either the absorption half-life or the mean absorption time (statistical moment term) will provide an estimate of the rate of absorption. The method of corresponding areas is the usual technique employed in estimating the extent of absorption (systemic availability). Inherent in this technique is the assumption that clearance of the drug remains unchanged. In horses, the time of feeding relative to oral dosing has been shown to affect systemic availability (rifampin, trimethoprim) and pattern of absorption (phenylbutazone). Oral paste formulations (trimethoprim-sulphadiazine, ivermectin) are convenient to administer, allow precision in dosage compared with powders or granules added to feed, and could provide sustained release. Assessment of bioequivalence is based on relative bioavailability, using a reference dosage form, together with a measure of the uncertainty (variance) of the estimate. Bioequivalence relies on the concept that preparations of a drug which provide essentially equivalent plasma concentration profiles should produce the same therapeutic effect.
Publication Date: 1992-06-01 PubMed ID: 1433478DOI: 10.1111/j.1365-2885.1992.tb01003.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research paper discusses how the method of administration and the formulation of veterinary medication affect how drugs are absorbed, which then impacts the intensity and duration of the drug’s effect. This study also discusses how the location of the administration site can affect the concentration of the drug in the animal’s plasma and how absorption directly impacts the rate of drug elimination. The article further studies the impact of feeding times relative to oral drug dosing in horses and the convenience of oral paste formulations. It concluded by examining the assessment of bioequivalence which relies on the concept that preparations of a drug which provide essentially similar plasma concentration profiles should produce the same therapeutic effect.

Factors Affecting Bioavailability

  • The research discusses how the route of administration and the formulation of the drug dosage form can affect its bioavailability, which includes the rate and extent of absorption of a drug. This, in turn, can impact the duration and intensity of the drug’s pharmacological effect on the animal.
  • It highlights that the site of injection can affect the plasma concentration profile of drugs administered as aqueous suspensions or sustained-release parenteral preparations.
  • The phenomenon called ‘flip-flop’ is discussed, where the rate of drug elimination is influenced by the rate of absorption, thereby increasing the apparent half-life of the drug.

Absorption and Impact of Feeding Time

  • Absorption is shown to approximate a first-order process, and the absorption half-life or the mean absorption time can provide a close estimate of the rate of absorption.
  • The research notes that the feeding time relative to oral dosing can affect systemic availability and also the pattern of absorption in horses, with mention of specific drugs like rifampin, trimethoprim, and phenylbutazone.

Oral Pastes and Bioequivalence

  • Oral paste formulations are discussed as a convenient method to administer drugs, providing precision in dosage compared with powders or granules added to feed. They could also potentially provide sustained release of medication.
  • The study further delves into the assessment of bioequivalence, which leans on the idea that preparations of a drug which provide similar plasma concentration profiles should yield the same therapeutic effect. The concept of relative bioavailability is used, incorporating a reference dosage form and a measure of the uncertainty of the estimate.

Cite This Article

APA
Baggot JD. (1992). Bioavailability and bioequivalence of veterinary drug dosage forms, with particular reference to horses: an overview. J Vet Pharmacol Ther, 15(2), 160-173. https://doi.org/10.1111/j.1365-2885.1992.tb01003.x

Publication

ISSN: 0140-7783
NlmUniqueID: 7910920
Country: England
Language: English
Volume: 15
Issue: 2
Pages: 160-173

Researcher Affiliations

Baggot, J D
  • Irish Equine Centre, Johnstown, County Kildare, Ireland.

MeSH Terms

  • Absorption
  • Administration, Oral
  • Animals
  • Biological Availability
  • Delayed-Action Preparations
  • Horses / metabolism
  • Injections / veterinary
  • Pharmaceutical Preparations / administration & dosage
  • Research Design
  • Statistics as Topic
  • Therapeutic Equivalency

Citations

This article has been cited 6 times.
  1. Martinez MN, Papich MG, Fahmy R. Impact of gastrointestinal differences in veterinary species on the oral drug solubility, in vivo dissolution, and formulation of veterinary therapeutics. ADMET DMPK 2022;10(1):1-25.
    doi: 10.5599/admet.1140pubmed: 35360673google scholar: lookup
  2. Davis JL, Schirmer J, Medlin E. Pharmacokinetics, pharmacodynamics and clinical use of trazodone and its active metabolite m-chlorophenylpiperazine in the horse. J Vet Pharmacol Ther 2018 Jun;41(3):393-401.
    doi: 10.1111/jvp.12477pubmed: 29333613google scholar: lookup
  3. Zozaya H, Gutierrez L, Bernad MJ, Sumano H. Pharmacokinetics of a peroral single dose of two long-acting formulations and an aqueous formulation of doxycycline hyclate in horses. Acta Vet Scand 2013 Mar 8;55(1):21.
    doi: 10.1186/1751-0147-55-21pubmed: 23497696google scholar: lookup
  4. Yáñez JA, Remsberg CM, Sayre CL, Forrest ML, Davies NM. Flip-flop pharmacokinetics--delivering a reversal of disposition: challenges and opportunities during drug development. Ther Deliv 2011 May;2(5):643-72.
    doi: 10.4155/tde.11.19pubmed: 21837267google scholar: lookup
  5. Serrano-Rodríguez JM, Miraz R, Saitua A, Díez de Castro E, Ledesma-Escobar C, Ferreiro-Vera C, Priego-Capote F, Sánchez de Medina V, Sánchez de Medina A. Metabolism, pharmacokinetics, and bioavailability of cannabigerol in horses following intravenous and oral administration with micellar and oil formulations. Front Vet Sci 2025;12:1688214.
    doi: 10.3389/fvets.2025.1688214pubmed: 41234397google scholar: lookup
  6. Thomson ACS, McCarrel TM, Zakharov A, Gomez B, Lyubimov A, Schwark WS, Mallicote MF, Portela DA, Bisiau AL, Wakshlag JJ. Pharmacokinetics and tolerability of single-dose enteral cannabidiol and cannabidiolic acid rich hemp in horses (Equus caballus). Front Vet Sci 2024;11:1356463.
    doi: 10.3389/fvets.2024.1356463pubmed: 38681854google scholar: lookup